INI-4001

INI-4001 has been studied in 1 paper since 2025: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Oct 28, 2025: “Elicitation of protective immune responses against influenza a viruses in elderly ferrets by adjuvanted recombinant universal influenza hemagglutinin vaccines”.

Intervention

1 paper studies itUpdated

PubChem

See all 1 papers on INI-4001

At a glance

1 trial, none about aging.

Cells, worms or flies, mice and humans: nothing yet.
  • 1 trial, none about aging
  • 1 of 1 trial sponsored by its developers
  • Animals1

Who is developing INI-4001?

1 company: Inimmune.

Companies
  • InimmunePhase 1advanced solid tumor

Trial sponsors

Latest